Related Experiment Video

Updated: Jun 16, 2026

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
09:58

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

Nuclear factor (erythroid-derived 2)-like 2 regulates drug resistance in pancreatic cancer cells

Young Bin Hong1, Hyo Jin Kang, Sun Young Kwon

  • 1Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057-1469, USA.

Pancreas
|February 2, 2010
PubMed
Abstract

Insights

Pancreatic cancers exhibit drug resistance due to elevated nuclear factor (erythroid-derived 2)-like 2 (Nrf2) levels. Targeting Nrf2 may lead to new pancreatic cancer treatments.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Pancreatic cancer is characterized by intrinsic drug resistance.
  • The molecular mechanisms underlying this resistance are not fully understood.
  • Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is a key regulator of cellular defense mechanisms.

Purpose of the Study:

  • To investigate the role of Nrf2 in the molecular basis of pancreatic cancer drug resistance.
  • To explore the relationship between Nrf2 expression and the efficacy of chemotherapy in pancreatic cancer.

Main Methods:

  • Analyzed Nrf2 expression in pancreatic cancer tissues and cell lines.
  • Manipulated Nrf2 and ABCG2 (adenosine 5'-triphosphate-binding cassette, subfamily G member 2) levels via overexpression and knock-down.
  • Assessed cell viability and ABCG2 activity (Hoechst 33342 staining) to determine drug resistance.

Main Results:

  • Elevated Nrf2 protein levels were observed in pancreatic cancer compared to normal tissues.
  • Increased Nrf2 levels correlated with enhanced drug resistance, while decreased levels led to sensitivity.
  • Expression of Nrf2 downstream genes and ABCG2 also correlated with drug resistance.

Conclusions:

  • Abnormally high Nrf2 protein levels contribute to the intrinsic drug resistance of pancreatic cancer.
  • Regulating Nrf2 activity presents a potential therapeutic strategy for overcoming pancreatic cancer drug resistance.
  • Further research into Nrf2 modulation could yield novel pancreatic cancer therapies.

More Related Videos

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype14:51

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...